These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 22578111
1. Discovery and optimization of a series of 2-aryl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazoles as novel anticancer agents. Romagnoli R, Baraldi PG, Salvador MK, Preti D, Aghazadeh Tabrizi M, Brancale A, Fu XH, Li J, Zhang SZ, Hamel E, Bortolozzi R, Porcù E, Basso G, Viola G. J Med Chem; 2012 Jun 14; 55(11):5433-45. PubMed ID: 22578111 [Abstract] [Full Text] [Related]
2. Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors. Romagnoli R, Baraldi PG, Remusat V, Carrion MD, Cara CL, Preti D, Fruttarolo F, Pavani MG, Tabrizi MA, Tolomeo M, Grimaudo S, Balzarini J, Jordan MA, Hamel E. J Med Chem; 2006 Oct 19; 49(21):6425-8. PubMed ID: 17034150 [Abstract] [Full Text] [Related]
3. Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues. Romagnoli R, Baraldi PG, Cruz-Lopez O, Lopez Cara C, Carrion MD, Brancale A, Hamel E, Chen L, Bortolozzi R, Basso G, Viola G. J Med Chem; 2010 May 27; 53(10):4248-58. PubMed ID: 20420439 [Abstract] [Full Text] [Related]
4. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition. Romagnoli R, Kimatrai Salvador M, Schiaffino Ortega S, Baraldi PG, Oliva P, Baraldi S, Lopez-Cara LC, Brancale A, Ferla S, Hamel E, Balzarini J, Liekens S, Mattiuzzo E, Basso G, Viola G. Eur J Med Chem; 2018 Jan 01; 143():683-698. PubMed ID: 29220790 [Abstract] [Full Text] [Related]
5. Synthesis, antimitotic and antivascular activity of 1-(3',4',5'-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles. Romagnoli R, Baraldi PG, Salvador MK, Prencipe F, Bertolasi V, Cancellieri M, Brancale A, Hamel E, Castagliuolo I, Consolaro F, Porcù E, Basso G, Viola G. J Med Chem; 2014 Aug 14; 57(15):6795-808. PubMed ID: 25025853 [Abstract] [Full Text] [Related]
6. Synthesis and biological evaluation of diarylthiazole derivatives as antimitotic and antivascular agents with potent antitumor activity. Wang F, Yang Z, Liu Y, Ma L, Wu Y, He L, Shao M, Yu K, Wu W, Pu Y, Nie C, Chen L. Bioorg Med Chem; 2015 Jul 01; 23(13):3337-50. PubMed ID: 25937236 [Abstract] [Full Text] [Related]
7. One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazole: a unique, highly active antimicrotubule agent. Romagnoli R, Baraldi PG, Lopez Cara C, Kimatrai Salvador M, Bortolozzi R, Basso G, Viola G, Balzarini J, Brancale A, Fu XH, Li J, Zhang SZ, Hamel E. Eur J Med Chem; 2011 Dec 01; 46(12):6015-24. PubMed ID: 22027100 [Abstract] [Full Text] [Related]
8. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents. Romagnoli R, Baraldi PG, Pavani MG, Tabrizi MA, Preti D, Fruttarolo F, Piccagli L, Jung MK, Hamel E, Borgatti M, Gambari R. J Med Chem; 2006 Jun 29; 49(13):3906-15. PubMed ID: 16789746 [Abstract] [Full Text] [Related]
9. Convergent synthesis and biological evaluation of 2-amino-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles as microtubule targeting agents. Romagnoli R, Baraldi PG, Brancale A, Ricci A, Hamel E, Bortolozzi R, Basso G, Viola G. J Med Chem; 2011 Jul 28; 54(14):5144-53. PubMed ID: 21663319 [Abstract] [Full Text] [Related]
10. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization. Romagnoli R, Baraldi PG, Carrion MD, Lopez Cara C, Preti D, Fruttarolo F, Pavani MG, Tabrizi MA, Tolomeo M, Grimaudo S, Di Cristina A, Balzarini J, Hadfield JA, Brancale A, Hamel E. J Med Chem; 2007 May 03; 50(9):2273-7. PubMed ID: 17419607 [Abstract] [Full Text] [Related]
11. Concise synthesis and biological evaluation of 2-Aryl-3-Anilinobenzo[b]thiophene derivatives as potent apoptosis-inducing agents. Romagnoli R, Preti D, Hamel E, Bortolozzi R, Viola G, Brancale A, Ferla S, Morciano G, Pinton P. Bioorg Chem; 2021 Jul 03; 112():104919. PubMed ID: 33957538 [Abstract] [Full Text] [Related]
12. Synthesis and Biological Evaluation of 2-Substituted Benzyl-/Phenylethylamino-4-amino-5-aroylthiazoles as Apoptosis-Inducing Anticancer Agents. Oliva P, Onnis V, Balboni E, Hamel E, Estévez-Sarmiento F, Quintana J, Estévez F, Brancale A, Ferla S, Manfredini S, Romagnoli R. Molecules; 2020 May 06; 25(9):. PubMed ID: 32384805 [Abstract] [Full Text] [Related]
13. Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency. Wang Y, Sun M, Wang Y, Qin J, Zhang Y, Pang Y, Yao Y, Yang H, Duan Y. Eur J Med Chem; 2021 Dec 05; 225():113790. PubMed ID: 34454126 [Abstract] [Full Text] [Related]
14. Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity. Romagnoli R, Baraldi PG, Salvador MK, Preti D, Aghazadeh Tabrizi M, Brancale A, Fu XH, Li J, Zhang SZ, Hamel E, Bortolozzi R, Basso G, Viola G. J Med Chem; 2012 Jan 12; 55(1):475-88. PubMed ID: 22136312 [Abstract] [Full Text] [Related]
15. Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-aryl/arylaminobenzo[b]thiophene derivatives as a novel class of antiproliferative agents. Romagnoli R, Baraldi PG, Cara CL, Hamel E, Basso G, Bortolozzi R, Viola G. Eur J Med Chem; 2010 Dec 12; 45(12):5781-91. PubMed ID: 20933308 [Abstract] [Full Text] [Related]
16. New thiazole-2(3H)-thiones containing 4-(3,4,5-trimethoxyphenyl) moiety as anticancer agents. Ansari M, Shokrzadeh M, Karima S, Rajaei S, Fallah M, Ghassemi-Barghi N, Ghasemian M, Emami S. Eur J Med Chem; 2020 Jan 01; 185():111784. PubMed ID: 31669850 [Abstract] [Full Text] [Related]
17. Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition. Viola G, Cecconet L, Leszl A, Basso G, Brun P, Salvador A, Dall'Acqua F, Diana P, Barraja P, Cirrincione G. Cancer Chemother Pharmacol; 2009 Nov 01; 64(6):1235-51. PubMed ID: 19363609 [Abstract] [Full Text] [Related]
18. Discovery of novel 2-N-aryl-substituted benzenesulfonamidoacetamides: orally bioavailable tubulin polymerization inhibitors with marked antitumor activities. Liu Z, Zhou Z, Tian W, Fan X, Xue D, Yu L, Yu Q, Long YQ. ChemMedChem; 2012 Apr 01; 7(4):680-93. PubMed ID: 22311585 [Abstract] [Full Text] [Related]
19. Design and synthesis of 2-heterocyclyl-3-arylthio-1H-indoles as potent tubulin polymerization and cell growth inhibitors with improved metabolic stability. La Regina G, Bai R, Rensen W, Coluccia A, Piscitelli F, Gatti V, Bolognesi A, Lavecchia A, Granata I, Porta A, Maresca B, Soriani A, Iannitto ML, Mariani M, Santoni A, Brancale A, Ferlini C, Dondio G, Varasi M, Mercurio C, Hamel E, Lavia P, Novellino E, Silvestri R. J Med Chem; 2011 Dec 22; 54(24):8394-406. PubMed ID: 22044164 [Abstract] [Full Text] [Related]
20. Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors. Wang G, Liu W, Fan M, He M, Li Y, Peng Z. J Enzyme Inhib Med Chem; 2021 Dec 22; 36(1):1694-1702. PubMed ID: 34309466 [Abstract] [Full Text] [Related] Page: [Next] [New Search]